GLPwatch
Papers (9189)
Page 136 of 154, ranked by citation count.
- Comparison of trajectories of self-monitored glucose levels by hypoglycemia status over 52 weeks of treatment with insulin glargine or exenatide once weekly.
- ▾ Liraglutide for weight management.
- Liraglutide for patients with non-alcoholic steatohepatitis - Authors' reply.
- In type 2 diabetes treated with high-dose insulin, liraglutide reduced HBA1c.
- Is Liraglutide Associated With Myocardial Protection in ST-Elevation Myocardial Infarction?
- Comparative ocular outcomes of tirzepatide versus other anti-obesity medications in people with obesity.
- [Extrapancreatic effects of GLP-1 receptor agonists: an open window towards new treatment goals in type 2 diabetes].
- Therapy for HFpEF: A step forward brings new hope for people with obesity and diabetes.
- Endoscopic and Open Carpal Tunnel Release in Patients With Type II Diabetes Mellitus: Influence of Preoperative Semaglutide Use on Postoperative Outcomes.
- Semaglutide ameliorates retinal vascular permeability destruction in diabetic retinopathy by AnxA2-mediated MMP-9 activation and basement membrane remodeling.
- Budget impact of introducing oral semaglutide to the public healthcare benefit package in Saudi Arabia.
- Once-Weekly Tirzepatide Versus Once-Daily Basal Insulin in Managing Type 2 Diabetes Inadequately Controlled With Oral anti-Hyperglycemic Drugs: A Systematic Review and Meta-Analysis.
- Recent diabetes issues affecting the primary care clinician.
- Long-term efficacy of daily oral semaglutide as add-on or switch therapy in adults with type 2 diabetes: a 12-month real-world retrospective study.
- Association learning is impaired in insulin resistance and restored by liraglutide.
- Glucagon-like peptide-1 agonists alleviate adenine-induced nephrotoxicity in rats: interaction with the renin-angiotensin system and role of NLRP-3 inflammasome, nephrin and KIM-1.
- More on Semaglutide in Early Type 1 Diabetes.
- High Dose of Liraglutide Impairs Renal Function in Female Hypertensive Rats.
- Liraglutide-Driven Weight Loss Modulates Placental Remodeling in Obese Pregnancies in Mice.
- Efficacy and safety of semaglutide in a diabetic and obese patient on incremental hemodialysis. Does it also contribute to preserving residual renal function?
- Semaglutide vs Tirzepatide Dosages for Weight Loss-Reply.
- Experience with dulaglutide in a diabetic and obese patient on incremental peritoneal dialysis.
- The adverse effects associated with tirzepatide use in patients at increased risk of cardiovascular events: a systematic review with meta-analysis and Trial Sequential Analysis.
- [Liraglutid can support weight loss].
- Response to "Experience with dulaglutide in an obese diabetic patient on incremental peritoneal dialysis". Response to related letter.
- Psychometric Validation of the Simplicity of Diabetes Treatment Questionnaire (Sim-Q) for Type 2 Diabetes.
- Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial.
- From Glycemic Control to Weight-Centered Therapy: A Paradigm Shift in Type 2 Diabetes and Its Public Health Promise.
- Comparison table: Some FDA-approved drugs for weight management.
- Exenatide Is Neuroprotective in a New Rabbit Model of Hypoxia-Ischemia.
- dulaglutide (Trulicity°) weekly in type 2 diabetes: Cardiovascular reactions should be better documented.
- Prescribing GLPs for Obesity Treatment for Adults at a University Based Health Maintenance Organization by Race, Ethnicity, and Socioeconomic Status.
- Liquid Chromatography Evaluation of a Novel Graphitic Carbon Stationary Phase Using Glucagon-Like Peptide‑1 Analogs.
- Effectiveness of Telemedicine Prescribing and a Long-Acting Obesity Medication Behavioral Program: A 24-Week Single-Arm Study.
- Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a multi-centre, randomised, double-blind, placebo-controlled, phase 3 trial.
- Prospective Comparative Analysis of Synchronous Abdominoplasty and Mastopexy in Bariatric and Nonbariatric Massive Weight Loss Patients: Highlighting the Rising Trend of GLP-1 Analog Use.
- The promoting roles of GLP1R and GIPR in stemness maintenance and multiple lineage-specific differentiation of PDLSCs.
- A review of survodutide: a new dual acting agonist.
- The effects of glucagon-like peptide-1 receptor agonists on fertility, contraception, and pregnancy: clinical perspectives.
- Prevalence of Obesity Medications in the Military Health System: An Update from 2022.
- Mazdutide Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating Endoplasmic Reticulum Stress, Improving Lipid Metabolism and Alleviating Inflammation.
- Comparative Efficacy and Safety of Ecnoglutide in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
- Preoperative GLP-1 Receptor Agonists and Thromboinflammatory Markers in Patients Undergoing Abdominoplasty: A Prospective Monocentric Study.
- Pharmacologic Treatment of Obesity in the Context of Type 2 Diabetes.
- Evaluating the Efficacy, Safety, and Practical Considerations of Semaglutide for Weight Loss in Non-Diabetic Adults: A Narrative Review.
- Therapeutic Potential of GLP-1 Receptor Agonists for Smoking Cessation.
- Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies.
- Pharmacological progress in obesity: tirzepatide's rising advantage over semaglutide.
- Oral delivery of peptides and proteins: pharmacokinetic boundaries, negative selection, and route triage.
- Effects of GLP-1 receptor agonists on copeptin in euvolemic participants.
- Effect of Tirzepatide on the Risk of Developing Type 2 Diabetes Mellitus Among the People Living With Obesity or Overweight: A Systematic Review.
- [Emerging GLP-1 analogues and dipeptidyl peptidase 4(DPP-4) inhibitors].
- Medication Adherence in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
- Glucagon-like peptide-1 receptor agonists may decrease biologic initiation in hidradenitis suppurativa: A TriNetX retrospective analysis.
- [Potential of a GLP-1 receptor agonist combined with basal insulin in the treatment of type 2 diabetes].
- Glucagon-like peptide 1 receptor agonists in substance use disorders: A systematic review of ClinicalTrials.Gov.
- Vascular and Myocardial Function in Patients with Type 2 Diabetes and Ischemic Stroke Treated with Dulaglutide or Empagliflozin.
- Liraglutide in Prader Willi-Syndrome: The Importance of Placebo-Controlled Studies.
- Multiple analysis based on dual-mode anion-exchange chromatography strategy reveals significant impact of charge heterogeneity on structure and function of dulaglutide.
- [Liraglutide reduces biomarkers and vascular risk in patients with diabetes mellitus type 2].